Investing.com - Quest Diagnostics (NYSE:DGX) reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Quest Diagnostics announced earnings per share of $0.94 on revenue of $1.82B. Analysts polled by Investing.com anticipated EPS of $1.07 on revenue of $1.83B. That with comparison to EPS of $1.4 on revenue of $1.89B in the same period a year before.Quest Diagnostics had reported EPS of $1.67 on revenue of $1.93B in the previous quarter.Analysts are expecting EPS of $0.41 and revenue of $1.61B in the upcoming quarter.
Quest Diagnostics shares are down 11% from the beginning of the year and are trading at $94.46 , down-from-52-week-high.They are outperforming the S&P 500 which is down 15.66% year to date.
Quest Diagnostics follows other major Healthcare sector earnings this month
Quest Diagnostics's report follows an earnings beat by J&J on Tuesday, April 14, 2020, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Abbott Labs had beat expectations on Thursday, April 16, 2020 with first quarter EPS of $0.65 on revenue of $7.73B, compared to forecast for EPS of $0.59 on revenue of $7.44B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar